Results tagged‘Author: Julian Wolfson’

Abstract: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) reduce the risk for several adverse outcomes among patients with diabetic kidney disease. Yet, optimal timing for …

Abstract: BACKGROUND: The effect of SGLT2i on kidney function after acute kidney injury (AKI) is unknown. METHODS: The study population was drawn from a retrospective cohort of …

Abstract: Significance Statement: Among patients with CKD, optimal use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers after AKI is uncertain. …